QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Aptose BiosciencesSolid BiosciencesCardiff OncologyLineage Cell TherapeuticsInnate Pharma
SymbolNASDAQ:APTONASDAQ:SLDBNASDAQ:CRDFNYSEAMERICAN:LCTXOTCMKTS:IPHYF
Price Information
Current Price$4.04$8.52$10.74$2.41$4.53
52 Week RangeBuyBuyBuyBuyBuy
MarketRank™
Overall Score1.41.11.71.60.6
Analysis Score3.51.33.53.50.0
Community Score2.72.63.43.02.8
Dividend Score0.00.00.00.00.0
Ownership Score0.80.80.80.80.0
Earnings & Valuation Score0.00.60.60.60.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$11.63$7.13$23.75$5.33N/A
% Upside from Price Target187.75% upside-16.37% downside121.14% upside121.30% upsideN/A
Trade Information
Market Cap$358.91 million$515.03 million$379.39 million$361.48 million$355.79 million
Beta1.621.11.82.111.06
Average Volume982,4201,254,0892,389,7372,149,8003,111
Sales & Book Value
Annual RevenueN/AN/A$250,000.00$3.52 million$96.12 million
Price / SalesN/AN/A1,517.56102.693.70
CashflowN/AN/AN/A$0.18 per shareN/A
Price / CashN/AN/AN/A13.32N/A
Book Value$1.23 per share$1.74 per share$0.94 per share$0.74 per share$4.23 per share
Price / BookN/AN/A11.433.261.07
Profitability
Net Income$-26,280,000.00$-117,220,000.00$-16,410,000.00$-11,710,000.00$-23,250,000.00
EPS($0.52)($2.91)($2.80)$0.14N/A
Trailing P/E RatioN/AN/AN/AN/A0.00
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-4,990.52%-1,001.59%N/A
Return on Equity (ROE)-49.53%-194.22%-95.03%-26.07%N/A
Return on Assets (ROA)-46.65%-140.40%-71.77%-22.91%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.03%N/AN/AN/A
Current Ratio24.60%1.84%7.02%5.13%1.99%
Quick Ratio24.60%1.84%7.02%5.13%N/A
Ownership Information
Institutional Ownership Percentage52.22%42.73%52.97%35.72%N/A
Insider Ownership Percentage6.30%31.20%0.60%29.00%N/A
Miscellaneous
Employees311211250247
Shares Outstanding88.84 million60.45 million35.33 million149.99 million78.54 million
Next Earnings Date3/9/2021 (Estimated)3/11/2021 (Estimated)5/27/2021 (Estimated)3/11/2021 (Estimated)3/9/2021 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.